Evidence of White Matter Neuroinflammation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Diffusion-Based Neuroinflammation Imaging Study. — CFSMEATLAS
Evidence of White Matter Neuroinflammation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Diffusion-Based Neuroinflammation Imaging Study.
Yu, Qiang, Kothe, Kiana, Kwiatek, Richard A et al. · Human brain mapping · 2026 · DOI
Quick Summary
This study used advanced brain imaging to look for signs of inflammation in the white matter (the brain's communication cables) of ME/CFS patients compared to healthy people. Researchers found several differences in how water moves through brain tissue in ME/CFS patients, suggesting there may be swelling, immune cell activity, and changes to nerve fibers. These imaging markers could potentially help doctors identify and track ME/CFS in the future.
Why It Matters
This research provides the first in vivo neurobiological evidence that ME/CFS involves measurable white matter inflammation, potentially validating the neuroinflammatory hypothesis central to ME/CFS pathophysiology. If NII-derived metrics are validated in larger studies, they could serve as objective diagnostic or prognostic biomarkers, addressing a critical unmet need in ME/CFS diagnosis and treatment monitoring.
Observed Findings
ME/CFS patients showed significantly reduced hindered water ratio and restricted fraction across white matter tracts, consistent with cerebral edema and immune cell infiltration.
ME/CFS patients exhibited increased fiber fraction, axial diffusivity, and mean diffusivity, suggesting axonal structural reorganization.
Lower restricted fraction, axial diffusivity, and mean diffusivity in ME/CFS patients correlated with worse mental health outcomes.
Lower restricted fraction was associated with higher disability levels in ME/CFS patients.
Conventional DTI metrics showed minimal group differences and no significant clinical associations, whereas NII metrics were sensitive to disease-related changes.
Inferred Conclusions
White matter neuroinflammation characterized by cerebral edema, cellular infiltration, and axonal reorganization is present in ME/CFS.
Neuroinflammation imaging-derived indices are more sensitive biomarkers for detecting ME/CFS-related brain changes than conventional DTI.
White matter neuroinflammatory markers correlate with mental health and disability severity, suggesting potential pathophysiological links to symptoms.
Remaining Questions
Are these white matter changes specific to ME/CFS or do they occur in other chronic conditions with neuroinflammatory features?
What This Study Does Not Prove
This study does not prove that white matter inflammation causes ME/CFS symptoms—only that differences exist in cross-sectional comparison. It does not establish whether these neuroinflammatory changes are primary drivers or secondary consequences of the disease. The findings require replication in independent cohorts and longitudinal follow-up to confirm causality and clinical utility.